Skip to content
Neuropediatoolkit

Neuropediatoolkit

  • Toolkit
  • Guía clínica
  • Criterios de remisión
  • Escuela
  • Lab
  • Archiv
  • Um

PTEN.

Posted byAlberto Alcantud 11 de September de 202222 de June de 2026

PHTS-Stiftung.

Posted byAlberto Alcantud11 de September de 202222 de June de 2026Posted inOnkologisches Risiko

Post navigation

Previous Post Previous post:
Neurofibromatose Typ 1.
Next Post Next post:
Neurogenetische Störungen und onkologisches Risiko.
Neuropediatoolkit, Proudly powered by WordPress.
German
Spanish English French Russian Chinese Japanese